ALTH » Topics » SIGNATURE

This excerpt taken from the ALTH 8-K filed Mar 14, 2006.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 14, 2006

ALLOS THERAPEUTICS, INC. (Registrant)

 

 

 

By:

/s/ Marc H. Graboyes

 

Name

Marc H. Graboyes

 

Title:

Vice President, General Counsel

 

5



 

This excerpt taken from the ALTH 8-K filed Mar 6, 2006.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: March 6, 2006

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

 

By:

/s/  MARC H. GRABOYES

 

 

Marc H. Graboyes

 

Its:

Vice President and General Counsel

 

 

 

3


This excerpt taken from the ALTH 8-K filed Mar 6, 2006.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 6, 2006

ALLOS THERAPEUTICS, INC. (Registrant)

 

 

 

By:

/s/ Marc H. Graboyes

 

Name

Marc H. Graboyes

 

Title:

Vice President, General Counsel

 

4



 

This excerpt taken from the ALTH 8-K filed Nov 9, 2005.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: November 9, 2005

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

 

By:

/s/  MICHAEL E. HART

 

 

Michael E. Hart

 

Its:

President and Chief Executive Officer

 

 

3


 

This excerpt taken from the ALTH 8-K filed Oct 21, 2005.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated:  October 21, 2005

 

 

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

 

 

 

 

By:

/s/ Marc Graboyes

 

 

Marc Graboyes

 

Its:

Vice President, General Counsel

 

3


 

This excerpt taken from the ALTH 8-K filed Oct 11, 2005.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated:  October 11, 2005

 

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

 

 

By:

/s/ Marc Graboyes

 

 

Marc Graboyes

 

Its:

Vice President, General Counsel

 

3


This excerpt taken from the ALTH 8-K filed Jun 16, 2005.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated:  June 16, 2005

 

 

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

 

 

 

 

By:

/s/ Michael E. Hart

 

 

 

Michael E. Hart

 

Its:

President and Chief Executive Officer

 

3


This excerpt taken from the ALTH 8-K filed May 23, 2005.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated:  May 23, 2005

 

 

 

 

 

 

 

 

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

 

 

 

 

By:

/s/ Marc H. Graboyes

 

 

Marc H. Graboyes

 

Its:

Vice President, General Counsel

 

4


This excerpt taken from the ALTH 8-K filed May 5, 2005.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: May 5, 2005

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

By:

/s/  MICHAEL E. HART

 

 

 

Michael E. Hart

 

Its:

President and Chief Executive Officer

 

3


 

This excerpt taken from the ALTH 8-K filed Feb 11, 2005.

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated:  February 11, 2005

 

 

 

 

 

 

 

ALLOS THERAPEUTICS, INC.

 

 

 

 

 

By:

/s/ Michael E. Hart

 

 

Michael E. Hart

 

Its:

President and Chief Executive Officer

 

4


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki